{{Rsnum
|rsid=12589282
|Gene=TRA@
|Chromosome=14
|position=22468664
|Orientation=plus
|GMAF=0.4348
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=LOC101929755,LOC102724753
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 31.9 | 48.7 | 19.5
| HCB | 29.2 | 48.2 | 22.6
| JPT | 27.4 | 49.6 | 23.0
| YRI | 15.1 | 56.8 | 28.1
| ASW | 21.1 | 47.4 | 31.6
| CHB | 29.2 | 48.2 | 22.6
| CHD | 17.0 | 52.8 | 30.2
| GIH | 38.6 | 47.5 | 13.9
| LWK | 25.5 | 50.0 | 24.5
| MEX | 58.6 | 25.9 | 15.5
| MKK | 25.8 | 42.6 | 31.6
| TSI | 37.3 | 49.0 | 13.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=4E-6
  |OR=1.48
  |ORtxt=[1.25-1.752]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}